CRISPR Startup Arbor Biotechnologies, Salk Institute Concurrently Discover New Cas13d Enzyme – GenomeWeb
|
CRISPR Startup Arbor Biotechnologies, Salk Institute Concurrently Discover New Cas13d Enzyme
GenomeWeb NEW YORK (GenomeWeb) – With $15.6 million in Series A funding, early-stage life sciences company Arbor Biotechnologies came out of stealth mode last week. But the new firm — which was cofounded by Broad Institute scientists and CRISPR experts Winston … |
